The role of regional anaesthesia in the emerging subspecialty of onco-anaesthesia: a state-of-the-art review

L Dockrell, D J Buggy, L Dockrell, D J Buggy

Abstract

Cancer accounts for millions of deaths globally each year, predominantly due to recurrence and metastatic disease. The majority of patients with primary solid organ cancers require surgery, however, some degree of tumour dissemination related to surgery is inevitable. The surgical stress response and associated immunosuppression, pain, inflammation, tissue hypoxia and angiogenesis have all been implicated in promoting tumour survival, proliferation and recurrence. Regional anaesthesia was hypothesised to reduce the surgical stress response and immunosuppression, minimise the need for volatile anaesthesia and reduce pain and opioid requirements, thus mitigating pro-tumour pathways associated with the peri-operative period and improving long-term oncological outcomes. While some retrospective studies suggested an association between regional anaesthesia and reduced cancer recurrence, the first large randomised controlled trial on the effect of anaesthetic technique on cancer outcome found no significant difference between paravertebral regional anaesthesia and volatile anaesthesia with opioid analgesia in patients undergoing breast cancer surgery. Randomised controlled trials on the long-term oncological outcomes of regional anaesthesia in other tumour types are ongoing. The focus on how peri-operative interventions, especially regional anaesthesia, during cancer resection surgery, may enhance short-term recovery and perhaps influence long-term outcome has spawned the global emergence of the subspecialty of onco-anaesthesia. This review aims to discuss the most recent evidence on the use of regional anaesthesia in cancer surgery and the significance of its role in onco-anaesthesia.

Keywords: cancer recurrence; onco-anaesthesia; peri-operative medicine; regional anaesthesia.

© 2021 Association of Anaesthetists.

References

    1. Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. International Journal of Cancer 2019; 144: 49-58.
    1. Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Critical Reviews in Oncogenesis 2013; 18: 43-73.
    1. Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncology 2015; 16: 1193-224.
    1. Wall T, Sherwin A, Ma D, Buggy DJ. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. British Journal of Anaesthesia 2019; 123: 135-50.
    1. Abdallah FW, Morgan PJ, Cil T, et al. Ultrasound-guided multilevel paravertebral blocks and total intravenous anesthesia improve the quality of recovery after ambulatory breast tumor resection. Anesthesiology 2014; 120: 703-13.
    1. Aloia TA, Kim BJ, Segraves-Chun YS, et al. A randomized controlled trial of postoperative thoracic epidural analgesia versus intravenous patient-controlled analgesia after major hepatopancreatobiliary surgery. Annals of Surgery 2017; 266: 545-54.
    1. Myles PS, Peyton P, Silbert B, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. British Medical Journal 2011; 342: d1491.
    1. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105: 660-4.
    1. Thota RS, Garg R, Ramkiran S, Divatia JV. Onco-anaesthesiology as an emerging sub-speciality domain: need of the hour!. Indian Journal of Anaesthesia 2020; 64: 69-71.
    1. Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. Journal of Surgical Oncology 2014; 110: 107-14.
    1. Merkow RP, Bilimoria KY, Tomlinson JS, et al. Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Annals of Surgery 2014; 260: 372-7.
    1. Slankamenac K, Slankamenac M, Schlegel A, et al. Impact of postoperative complications on readmission and long-term survival in patients following surgery for colorectal cancer. International Journal of Colorectal Disease 2017; 32: 805-11.
    1. Wigmore T, Gottumukkala V, Riedel B. Making the case for the subspecialty of onco-anesthesia. International Anesthesiology Clinics 2016; 54: 1928.
    1. Sessler DI, Ben-Eliyahu S, Mascha EJ, Parat MO, Buggy DJ. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contempory Clinical Trials 2008; 29: 517-26.
    1. Casey SC, Amedei A, Aquilano K, et al. Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology 2015; 35: S199-S223.
    1. Angka L, Khan ST, Kilgour MK, et al. Dysfunctional natural killer cells in the aftermath of cancer surgery. International Journal of Molecular Sciences 2017; 18: 1787.
    1. Alazawi W, Pirmadjid N, Lahiri R, Bhattacharya S. Inflammatory and immune responses to surgery and their clinical impact. Annals of Surgery 2016; 264: 73.
    1. Zhou D, Gu FM, Gao Q, Li QL, Zhou J, Miao CH. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy. World Journal of Gastroenterology 2012; 18: 3089-98.
    1. Chen WK, Ren L, Wei Y, Zhu DX, Miao CH, Xu JM. General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients. International Journal of Colorectal Disease 2015; 30: 475-81.
    1. Xu Y, Sun Y, Chen H, Wang Y, Wang GN. Effects of two different anesthetic methods on cellular immunity of patients after liver cancer resection. Journal of Biological Regulators and Homestatic Agents 2016; 30: 1099-106.
    1. Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, et al. Beta-adrenergic receptors in cancer: therapeutic implications. Oncology Research 2010; 19: 45.
    1. Wu WK, Sung JJ, Lee CW, et al. Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Letters 2010; 295: 7.
    1. Masoud GN, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharmaceutica Sinica B 2015; 5: 378.
    1. Huang H, Benzonana LL, Zhao H, et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. British Journal of Cancer 2014; 111: 1338.
    1. Karnezis T, Shayan R, Caesar C, et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 2012; 21: 181.
    1. Tavare AN, Perry NJ, Benzonana LL, et al. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. International Journal of Cancer 2012; 130: 1237.
    1. O’Riain SC, Buggy DJ, Kerin MJ, Watson RW, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesthesia and Analgesia 2005; 100: 244-9.
    1. Buggy DJ, Smith G. Epidural anaesthesia and analgesia: better outcome after major surgery? Growing evidence suggests so. British Medical Journal 1999; 319: 530-1.
    1. Kun L, Tang L, Wang J, Yang H, Ren J. Effect of combined general/epidural anesthesia on postoperative NK cell activity and cytokine response in gastric cancer patients undergoing radical resection. Hepato-Gastroenterology 2014; 61: 1142-7.
    1. Wang L, Liang S, Chen H, Xu Y, Wang Y. The effects of epidural anaesthesia and analgesia on T lymphocytes differentiation markers and cytokines in patients after gastric cancer resection. BioMed Central Anesthesiology 2019; 19: 102.
    1. Stollings LM, Jia LJ, Tang P, Dou H, Lu B, Xu Y. Immune modulation by volatile anesthetics. Anesthesiology 2016; 125: 399-411.
    1. Ecimovic P, McHugh B, Murray D, Doran P, Buggy DJ. Effects of sevoflurane on breast cancer cell function in vitro. Anticancer Research 2013; 33: 4255-60.
    1. Iwasaki M, Zhao H, Jaffer T, et al. Volatile anaesthetics enhance the metastasis related cellular signaling including CXCR2 of ovarian cancer cells. Oncotarget 2016; 7: 26042-56.
    1. Yuki K, Eckenhoff RG. Mechanisms of the immunological effects of volatile anesthetics: a review. Anesthesia and Analgesia 2016; 123: 326-35.
    1. Huang H, Benzonana LL, Zhao H, et al. Prostate cancer cell malignancy via modulation of HIF-1a pathway with isoflurane and propofol alone and in combination. British Journal of Cancer 2014; 111: 1338-49.
    1. Ciechanowicz S, Zhao H, Chen Q, et al. Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro. British Journal of Anaesthesia 2018; 120: 368-75.
    1. Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001; 90: 191-9.
    1. Heaney A, Buggy DJ. Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? British Journal of Anaesthesia 2012; 109: i17-i28.
    1. Connolly C, Buggy DJ. Opioids and tumour metastasis: does the 25 choice of the anesthetic-analgesic technique influence outcome after cancer surgery? Current Opinion in Anesthesiology 2016; 29: 468-74.
    1. Boland JW, Pockley AG. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. British Journal of Pharmacology 2018; 175: 2726-36.
    1. Zylla D, Gourley BL, Vang D, et al. Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer. Cancer 2013; 119: 4103-10.
    1. Zhang YF, Xu QX, Liao LD, et al. Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma. Diseases of the Esophagus 2015; 28: 196-203.
    1. Khabbazi S, Nassar ZD, Goumon Y, Parat MO. Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro. International Journal of Scientific Reports 2016; 6: 31572.
    1. Koodie L, Yuan H, Pumper JA, et al. Morphine inhibits migration of tumor-infiltrating leukocytes and sup- presses angiogenesis associated with tumor growth in mice. American Journal of Pathology 2014; 184: 1073-84.
    1. Afsharimani B, Baran J, Watanabe S, Lindner D, Cabot PJ, Parat MO. Morphine and breast tumor metastasis: the role of matrix-degrading enzymes. Clinical and Experimental Metastasis 2014; 31: 149-58.
    1. Diaz-Cambronero O, Mazzinari G, Cata JP. Perioperative opioids and colorectal cancer recurrence: a systematic review of the literature. Pain Management 2018; 8: 353.
    1. Dan J, Gong X, Li D, Zhu G, Wang L, Li F. Inhibition of gastric cancer by local anesthetic bupivacaine through multiple mechanisms independent of sodium channel blockade. Biomedicine and Pharmacotherapy 2018; 103: 823-8.
    1. Chamaraux-Tran TN, Piegeler T. The amide local anesthetic lidocaine in cancer surgery potential anti- metastatic effects and preservation of immune cell function? A narrative review. Frontiers in Medicine 2017; 4: 235.
    1. Lirk P, Hollmann MW, Fleischer M, Weber NC, Fiegl H. Lidocaine and ropivacaine, but not bupivacaine, de-methylate deoxyribonucleic acid in breast cancer cells in vitro. British Journal of Anaesthesia 2014; 113: i32-i38.
    1. Chang YC, Liu CL, Chen MJ, et al. Local anesthetics induce apoptosis in human breast tumor cells. Anesthesia and Analgesia 2014; 118: 116-24.
    1. Xuan W, Zhao H, Hankin J, Chen L, Yao S, Ma D. Local anesthetic bupivacaine induced ovarian and prostate cancer apoptotic cell death and underlying mechanisms in vitro. International Journal of Scientific Reports 2016; 6: 26277.
    1. Johnson MZ, Crowley PD, Foley AG, et al. Effect of peri-operative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model. British Journal of Anaesthesia 2018; 121: 76-85.
    1. Xing W, Chen DT, Pan JH, et al. Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology 2017; 126: 868-81.
    1. Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesthesia and Analgesia 2009; 109: 1464-9.
    1. Tsui BC, Rashiq S, Schopflocher D, et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Canadian Journal of Anesthesia 2010; 57: 107-12.
    1. Cakmakkaya OS, Kolodzie K, Apfel CC, Pace NL. Anaesthetic techniques for risk of malignant tumour recurrence. Cochrane Database of Systematic Reviews 2014; CD008877.
    1. Grandhi RK, Lee S, Abd-Elsayed A. The relationship between regional anesthesia and cancer: a metaanalysis. Ochsner Journal 2017; 17: 345-61.
    1. Deegan CA, Murray D, Doran P, et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Regional Anesthesia and Pain Medicine 2010; 35: 490-5.
    1. Looney M, Doran P, Buggy DJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor β in women undergoing anesthesia and surgery for breast cancer. Anesthesiology 2010; 113: 1118-25.
    1. Jaura AI, Flood G, Gallagher HC, Buggy DJ. Differential effects of serum from patients administered distinct anaesthetic techniques on apoptosis in breast cancer cells in vitro: a pilot study. British Journal of Anaesthesia 2014; 113: i63-i67.
    1. Buckley A, McQuaid S, Johnson P, Buggy DJ. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. British Journal of Anaesthesia 2014; 113: i56-i62.
    1. Desmond F, McCormack J, Mulligan N, Stokes M, Buggy DJ. Effect of anaesthetic technique on immune cell infiltration in breast cancer: a follow-up pilot analysis of a prospective, randomised, investigator-masked study. Anticancer Research 2015; 35: 1311-9.
    1. Levins KJ, Prendeville S, Conlon S, et al. The effect of anesthetic technique on µ-opioid receptor expression and immune cell infiltration in breast cancer. Journal of Anesthesia 2018; 32: 792-6.
    1. Gupta A, Björnsson A, Fredriksson M, Hallböök O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. British Journal of Anaesthesia 2011; 107: 164-70.
    1. Hiller JG, Hacking MB, Link EK, Wessels KL, Riedel BJ. Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery. Acta Anaesthesiologica Scandinavica 2014; 58: 281-90.
    1. Lee EK, Ahn HJ, Zo JI, Kim K, Jung DM, Park JH. Paravertebral block does not reduce cancer recurrence, but is related to higher overall survival in lung cancer surgery: a retrospective cohort study. Anesthesia and Analgesia 2017; 125: 1322-8.
    1. Ehlers O, Nachtigall I, Lenze J, et al. Intraoperative thoracic epidural anaesthesia attenuates stress-induced immunosuppression in patients undergoing major abdominal surgery. British Journal of Anaesthesia 2008; 101: 781-7.
    1. Vogelaar FJ, Abegg R, van der Linden JC, et al. Epidural analgesia associated with better survival in colon cancer. International Journal of Colorectal Disease 2015; 30: 1103-7.
    1. Gottschalk A, Ford JG, Regelin CC, et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010; 113: 27-34.
    1. Cummings KC 3rd, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology 2012; 116: 797-806.
    1. Holler JP, Ahlbrandt J, Burkhardt E, et al. Peridural analgesia may affect long-term survival in patients with colorectal cancer after surgery (PACO-RAS-Study): an analysis of a cancer registry. Annals of Surgery 2013; 258: 989-93.
    1. US National Library of Medicine. IRB-HSR# 13957: IV lidocaine for patients undergoing primary breast cancer surgery: effects on postoperative recovery and cancer recurrence. Clinical . 2010. (accessed 29/7/2020).
    1. Heinrich S, Janitz K, Merkel S, Klein P, Schmidt J. Short- and long term effects of epidural analgesia on morbidity and mortality of esophageal cancer surgery. Langenbeck’s Archives of Surgery 2015; 400: 19-26.
    1. Li W, Li Y, Huang Q, Ye S, Rong T. Short and long-term outcomes of epidural or intravenous analgesia after esophagectomy: a propensity-matched cohort study. PLoS One 2016; 11: e0154380.
    1. US National Library of Medicine. The effect of combined general/regional anesthesia on cancer recurrence in patients having lung cancer resection. Clinical . 2016. (accessed 29/7/2020).
    1. US National Library of Medicine. Epidural analgesia use in pancreatic resections (E-PRO I). Clinical . 2016. (accessed 29/7/2020).
    1. Wang Y, Wang L, Chen H, Xu Y, Zheng X, Wang G. The effects of intra- and post-operative anaesthesia and analgesia choice on outcome after gastric cancer resection: a retrospective study. Oncotarget 2017; 8: 62658-65.
    1. Zimmitti G, Soliz J, Aloia TA, et al. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Annals of Surgical Oncology 2016; 23: 1003-11.
    1. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008; 109: 180-7.
    1. Wuethrich PY, Hsu Schmitz SF, Kessler TM, et al. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 2010; 113: 570-6.
    1. Scavonetto F, Yeoh TY, Umbreit EC, et al. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. British Journal of Anaesthesia 2014; 113(Suppl 1): i95-i102.
    1. Choi WJ, Baek S, Joo EY, et al. Comparison of the effect of spinal anesthesia and general anesthesia on 5-year tumor recurrence rates after transurethral resection of bladder tumors. Oncotarget 2017; 8: 87667-74.
    1. Koumpan Y, Jaeger M, Mizubuti GB, et al. Spinal anesthesia is associated with lower recurrence rates after resection of nonmuscle invasive bladder cancer. Journal of Urology 2018; 199: 940-6.
    1. Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. British Journal of Anaesthesia 2011; 106: 814-22.
    1. de Oliveira GS Jr, Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Regional Anesthesia and Pain Medicine 2011; 36: 271-7.
    1. Tseng JH, Cowan RA, Afonso AM, et al. Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecological Oncology 2018; 151: 287-93.
    1. Starnes-Ott K, Goravanchi F, Meininger J. Anesthetic choices and breast cancer recurrence. Critical Care Nursing Quarterly 2015; 38: 200-10.
    1. Day A, Smith R, Jourdan I, Fawcett W, Scott M, Rockall T. Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer. British Journal of Anaesthesia 2012; 109: 185-90.
    1. Cummings KC, Patel M, Htoo PT, Bakaki PM, Cummings LC, Koroukian S. A comparison of the effects of epidural analgesia versus traditional pain management on outcomes after gastric cancer resection: a population-based study. Regional Anesthesia and Pain Medicine 2014; 39: 200-7.
    1. Shin S, Kim HI, Kim NY, Lee KY, Kim DW, Yoo YC. Effect of postoperative analgesia technique on the prognosis of gastric cancer: a retrospective analysis. Oncotarget 2017; 8: 104594-604.
    1. Forget P, Tombal B, Scholtès JL, et al. Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? European Journal of Anaesthesiology 2011; 28: 830-5.
    1. Wuethrich PY, Thalmann GN, Studer UE, Burkhard FC. Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancer. PLoS One 2013; 8: e72873.
    1. Roiss M, Schiffmann J, Tennstedt P, et al. Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter? European Journal of Surgical Oncology 2014; 40: 1686-92.
    1. Sprung J, Scavonetto F, Yeoh TY, et al. Outcomes after radical prostatectomy for cancer: a comparison between general anesthesia and epidural anesthesia with fentanyl analgesia: a matched cohort study. Anesthesia and Analgesia 2014; 119: 859-66.
    1. Tseng KS, Kulkarni S, Humphreys EB, et al. Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study. Regional Anesthesia and Pain Medicine 2014; 39: 284-8.
    1. Christopher Doiron R, Jaeger M, Booth CM, Wei X, Robert SD. Is there a measurable association of epidural use at cystectomy and postoperative outcomes? A population-based study. Canadian Urological Association Journal 2016; 10: 321-7.
    1. Weingarten TN, Taccolini AM, Ahle ST, et al. Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study. Canadian Journal of Anesthesia 2016; 63: 584-95.
    1. Chipollini J, Alford B, Boulware DC, et al. Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center. Biomed Central Anesthesiology 2018; 18: 157.
    1. Lacassie HJ, Cartagena J, Brañes J, Assel M, Echevarría GC. The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population. Anesthesia and Analgesia 2013; 117: 653-60.
    1. Capmas P, Billard V, Gouy S, et al. Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer. Anticancer Research 2012; 32: 1537-42.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever